Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Zohar

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Statistical Methods in Medical Research|September 6, 2017
Bayesian treatment comparison using parametric mixture priors computed from elicited histogramsPeter F Thall, Moreno Ursino, Véronique Baudouin, et al.
Statistics in Medicine|July 14, 2021
Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimensEmma Gerard, Sarah Zohar, Christelle Lorenzato, et al.
Clinical Trials (London, England)|October 2, 2008
Quality assessment of phase I dose-finding cancer trials: proposal of a checklistSarah Zohar, Qing Lian, Vincent Levy, et al.
Anesthesiology|May 8, 2013
Application of the continual reassessment method to dose-finding studies in regional anesthesia: an estimate of the ED95 dose for 0.5% bupivacaine for ultrasound-guided supraclavicular blockAbhinav Kant, Pawan Kumar Gupta, Sarah Zohar, et al.
BMC Medical Research Methodology|September 20, 2019
A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety eventsCamille Aupiais, Corinne Alberti, Thomas Schmitz, et al.
Blood Advances|December 19, 2022
Enriching single-arm clinical trials with external controls: possibilities and pitfallsJérôme Lambert, Etienne Lengliné, Raphaël Porcher, et al.
Statistical Methods in Medical Research|March 19, 2016
Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomizationMarie-Karelle Riviere, Ying Yuan, Jacques-Henri Jourdan, et al.
Clinical Pharmacokinetics|September 17, 2025
Modeling Whole-Body Dynamic PET Microdosing Data to Predict the Whole-Body Pharmacokinetics of Glyburide in HumansLéa Comin, Solène Marie, Moreno Ursino, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experiencePierre-François Dequin, Amélie Le Gouge, Elsa Tavernier, et al.
Pharmaceutical Statistics|October 6, 2010
Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomasSarah Zohar, Ileana Baldi, Guido Forni, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Statistical Methods in Medical Research|September 6, 2017
Bayesian treatment comparison using parametric mixture priors computed from elicited histogramsPeter F Thall, Moreno Ursino, Véronique Baudouin, et al.
Statistics in Medicine|July 14, 2021
Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimensEmma Gerard, Sarah Zohar, Christelle Lorenzato, et al.
Clinical Trials (London, England)|October 2, 2008
Quality assessment of phase I dose-finding cancer trials: proposal of a checklistSarah Zohar, Qing Lian, Vincent Levy, et al.
Anesthesiology|May 8, 2013
Application of the continual reassessment method to dose-finding studies in regional anesthesia: an estimate of the ED95 dose for 0.5% bupivacaine for ultrasound-guided supraclavicular blockAbhinav Kant, Pawan Kumar Gupta, Sarah Zohar, et al.
BMC Medical Research Methodology|September 20, 2019
A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety eventsCamille Aupiais, Corinne Alberti, Thomas Schmitz, et al.
Blood Advances|December 19, 2022
Enriching single-arm clinical trials with external controls: possibilities and pitfallsJérôme Lambert, Etienne Lengliné, Raphaël Porcher, et al.
Statistical Methods in Medical Research|March 19, 2016
Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomizationMarie-Karelle Riviere, Ying Yuan, Jacques-Henri Jourdan, et al.
Clinical Pharmacokinetics|September 17, 2025
Modeling Whole-Body Dynamic PET Microdosing Data to Predict the Whole-Body Pharmacokinetics of Glyburide in HumansLéa Comin, Solène Marie, Moreno Ursino, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experiencePierre-François Dequin, Amélie Le Gouge, Elsa Tavernier, et al.
Pharmaceutical Statistics|October 6, 2010
Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomasSarah Zohar, Ileana Baldi, Guido Forni, et al.
Pageof 9